Sheldon Laurence Spector

Sheldon Laurence Spector's AcademicInfluence.com Rankings

Philosophy

#7620

World Rank

#10859

Historical Rank

Logic

#4667

World Rank

#5986

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Sheldon Laurence Spector's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Sheldon Laurence Spector Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sheldon Laurence Spector's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Standardization of bronchial inhalation challenge procedures. (1975) (1465)
The diagnosis and management of rhinitis: an updated practice parameter. (2008) (1016)
Allergen immunotherapy: a practice parameter third update. (2007) (1005)
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. (2000) (878)
Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. (1998) (682)
Allergy diagnostic testing: an updated practice parameter. (2008) (668)
The diagnosis and management of anaphylaxis practice parameter: 2010 update. (2010) (660)
Practice parameter for the diagnosis and management of primary immunodeficiency. (2015) (638)
Food allergy: a practice parameter update-2014. (2014) (619)
Drug allergy: an updated practice parameter. (2010) (572)
The diagnosis and management of acute and chronic urticaria: 2014 update. (2014) (510)
Atopic dermatitis: a practice parameter update 2012. (2013) (366)
The diagnosis and management of sinusitis: a practice parameter update. (2005) (340)
Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. (1994) (337)
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. (2011) (329)
Anaphylaxis--a practice parameter update 2015. (2015) (320)
Stinging insect hypersensitivity: a practice parameter update. (2004) (317)
Food allergy: a practice parameter. (2006) (263)
Adverse reactions to vaccines practice parameter 2012 update. (2012) (245)
Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. (2004) (239)
Stinging insect hypersensitivity: a practice parameter update 2011. (2004) (234)
Overview of comorbid associations of allergic rhinitis. (1997) (228)
Aspirin and concomitant idiosyncrasies in adult asthmatic patients. (1979) (225)
Multidimensional Analysis of the Subjective Symptomatology of Asthma (1973) (217)
Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. (1986) (207)
Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. (2010) (206)
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study (2014) (204)
Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma (2009) (180)
Effect of omalizumab on patients with chronic urticaria. (2007) (163)
Diagnosis and management of rhinosinusitis: a practice parameter update. (2014) (162)
Stinging insect hypersensitivity (2004) (157)
Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitis☆☆☆ (1974) (152)
Yellow fever vaccine (1972) (151)
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. (2013) (141)
High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects. (2013) (135)
Symptom severity assessment of allergic rhinitis: part 1. (2003) (134)
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study. (2015) (131)
Compliance in clinical trials of two nonbronchodilator, antiasthma medications. (1991) (131)
Parameters for the diagnosis and management of sinusitis. (1998) (130)
The effect of troleandomycin on methylprednisolone elimination. (1980) (127)
Obervations on Subjective Symptomatology, Coping Behavior, and Medical Decisions in Asthma (1977) (126)
Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency (2010) (123)
Behavior abnormalities and poor school performance due to oral theophylline use. (1986) (121)
Environmental assessment and exposure control of dust mites: a practice parameter. (2013) (116)
A comparison of methacholine and histamine inhalations in asthmatics. (1975) (111)
Attaining optimal asthma control: a practice parameter. (2005) (110)
Efficacy of doxepin in the treatment of chronic idiopathic urticaria. (1986) (95)
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. (1998) (93)
Contact dermatitis: a practice parameter-update 2015. (2015) (91)
Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. (1995) (86)
Lung disease. (2000) (86)
STINGING INSECT HYPERSENSITIVITY: A PRACTICE PARAMETER ☆ ☆☆ ★ ★★ (1999) (83)
Bronchoconstrictive suggestion in asthma: a role for airways hyperreactivity and emotions. (1978) (83)
Response of asthmatics to methacholine and suggestion. (1976) (79)
Environmental assessment and exposure reduction of cockroaches: a practice parameter. (2013) (77)
Practice parameters for allergen immunotherapyabcde (1996) (74)
Exercise-induced asthma: diagnosis and management. (2002) (74)
The microbiology of chronic sinus disease in children with respiratory allergy. (1990) (68)
Bronchial inhalation procedures in asthmatics. (1974) (67)
Panic-fear: a personality dimension related to length of hospitalization in respiratory illness. (1977) (66)
Is a Single Blood Eosinophil Count a Reliable Marker for “Eosinophilic Asthma?” (2012) (64)
Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. (1992) (63)
Long-term follow-up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome. (2015) (63)
Development of a daily diary for patients with chronic idiopathic urticaria. (2010) (63)
Erratum: Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: A randomized, placebo-controlled study (Journal of Investigative Dermatology (2015) 135 (67-75)) DOI: 10.1038/jid.2014.306) (2015) (61)
A dose-response study of the bronchodilator action of azelastine in asthma. (1987) (61)
Medical Outcome in Asthmatic Patients: Effects of Airways Hyperreactivity and Symptom‐Focused Anxiety (1979) (59)
Antileukotrienes in chronic urticaria. (1998) (58)
Subjective symptoms of acute asthma within a heterogeneous sample of asthmatics. (1973) (58)
Update on exercise-induced asthma. (1993) (58)
Effectiveness of montelukast in the treatment of cough variant asthma. (2004) (58)
Observations on Patterns of Subjective Symptomatology of Acute Asthma (1974) (57)
Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. (2017) (57)
Correlation between A-mode ultrasound and radiography in the diagnosis of maxillary sinusitis. (1986) (56)
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic / Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines : A Randomized , Placebo-Controlled Study (2010) (55)
Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. (1998) (54)
Acute cough: a diagnostic and therapeutic challenge (2009) (54)
The natural history and response to therapy of chronic urticaria and angioedema. (1989) (54)
Environmental assessment and exposure reduction of rodents: a practice parameter. (2012) (53)
Validation of the Doser, a new device for monitoring metered-dose inhaler use. (1998) (52)
Effects of particulate air pollution on asthmatics. (1983) (52)
677 The therapeutic effects of MK-571, a potent and selective leukotriene (LT) D4 receptor antagonist, in patients with chronic asthma (1991) (52)
Paradoxical bronchospasm after use of inhalation aerosols: a review of the literature. (1991) (52)
Dose‐ and time‐related effect of troleandomycin on methylprednisolone elimination (1982) (51)
The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. (1983) (51)
Beneficial effects of propylene and polyethylene glycol and saline in the treatment of perennial rhinitis (1982) (48)
Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy. (1982) (48)
The role of allergy in sinusitis in adults. (1992) (47)
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. (2005) (47)
Safety of antileukotriene agents in asthma management. (2001) (46)
Prevalence of sensitization to aeroallergens in California patients with respiratory allergy. Allergy Skin Test Project Team. (1998) (46)
Pediatric sinusitis (2007) (45)
Provocation testing in clinical practice (1995) (44)
Allergy diagnostic testing: An updated practice parameter (Annals of Allergy, Asthma and Immunology (2008) 100, SUPPL. 3, (S1-S148)) (2008) (44)
Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma? (2003) (44)
Exercise-Induced Asthma (1998) (42)
As-needed medication use in asthma usage patterns and patient characteristics. (1993) (40)
Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. (1988) (39)
The common cold: Current therapy and natural history☆☆☆★ (1995) (39)
Bronchial inhalation challenge with antigens. (1979) (38)
Algorithm for the Diagnosis and Management of Asthma: a Practice Parameter Update (1998) (38)
Clinical and nasal biopsy response to treatment of perennial rhinitis. (1980) (37)
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. (2009) (36)
Yellow fever virus. I. Development and evaluation of a plaque neutralization test. (1968) (35)
Adverse reactions to vaccines. (1987) (35)
Pharmacodynamic evaluation of azelastine in subjects with asthma. (1987) (34)
Bronchial Provocation Tests (1987) (33)
Management of acute loss of asthma control in the yellow zone: a practice parameter. (2014) (33)
Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. (2011) (32)
Salmeterol versus theophylline in the treatment of asthma. (1997) (32)
Lysozyme levels in the nasal secretions of patients with perennial allergic rhinitis and recurrent sinusitis. (2004) (32)
Sinusitis and asthma. (1990) (31)
251 Azelastine (azel) in the treatment of asthma (1985) (31)
Comparison between transillumination and the roentgenogram in diagnosing paranasal sinus disease. (1981) (30)
Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis. (1992) (30)
Joint Task Force Algorithm and Annotations for Diagnosis and Management of Rhinitis. (1998) (30)
Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols. (1977) (28)
Efficacy and Safety of Oral Telithromycin Once Daily for 5 Days Versus Moxifloxacin Once Daily for 10 Days in the Treatment of Acute Bacterial Rhinosinusitis (2004) (28)
Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. (1990) (28)
320 Chronic sinusitis in children (1991) (26)
Asthma without wheezing. (1973) (26)
Relationship between airways response to allergens and nonspecific bronchial reactivity. (1979) (25)
Use of a tube spacer to improve the efficacy of a metered-dose inhaler in asthmatic children. (1986) (23)
Disease management of atopic dermatitis (2004) (23)
Efficacy of parenteral albuterol in the treatment of asthma. Comparison of its metabolic side effects with subcutaneous epinephrine. (1986) (23)
Provocative challenge procedures : background and methodology (1989) (23)
Is your asthmatic patient really complying? (1985) (23)
Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure. (2001) (23)
Treatment of perennial rhinitis with flunisolide corticosteroid spray. (1979) (22)
Twice-daily beclomethasone dipropionate in the treatment of childhood asthma. (1986) (22)
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies (2016) (21)
The use of cultures and immunologic procedures to predict oropharyngeal candidiasis in patients on steroid aerosols (1982) (21)
Ideal pharmacotherapy for allergic rhinitis. (1999) (21)
Asthma and pregnancy. (1979) (21)
Allergic inflammation in upper and lower airways. (1999) (21)
Effect of terfenadine in asthmatic patients. (1992) (20)
Evaluation of the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time. (1990) (20)
Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma. (2012) (20)
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. (2007) (20)
Advantages and disadvantages of 24-hour theophylline. (1985) (19)
Effect of a selective beta 2 adrenergic agonist and theophylline on skin test reactivity and cardiovascular parameters. (1979) (19)
Central nervous system effects of antiasthma medication--an EEG study. (1985) (19)
Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions. (1999) (18)
A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm. (1987) (18)
Effect of beta-adrenergic agents on skin test responses and bronchial challenge responses. (1978) (18)
Albuterol aerosol versus albuterol Rotacaps in exercise-induced bronchospasm in children. (1995) (17)
Comments on Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. (2011) (17)
Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma (2012) (17)
Clinical pulmonary tuberculosis in an asthmatic patient using a steroid aerosol. (1977) (17)
Asthma in the Workplace, 3rd edition. (2006) (16)
Leukotriene inhibitors and antagonists in asthma. (1995) (16)
The use of corticosteroids in the treatment of asthma. (1985) (16)
Alpha 1-antitrypsin deficiency and common variable hypogammaglobulinemia in a patient with asthma. (1982) (15)
The placebo effect is nothing to sneeze at. (1992) (15)
Yellow fever virus. II. Factors affecting the plaque neutralization test. (1969) (15)
Exercise-Induced Asthma: It Needn't Sideline Your Patients (1991) (15)
Differences in recommendations between the Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters. (2011) (15)
Omalizumab also successful in chronic urticaria. (2008) (15)
Calibration and stability of Standard and Mini-Wright peak flow meters. (1981) (14)
Omalizumab: efficacy in allergic disease. (2004) (14)
672 Comparison of efficacy and safety of albuterol administered by power-driven nebulizer (PDN) versus metered dose inhaler (MDI) with aerochamber and mask in young children with asthma (1991) (14)
Therapeutic alternatives for chronic urticaria: additional reports on omalizumab. (2008) (13)
Evaluation of aspirin and tartrazine idiosyncrasy. (1979) (13)
Diagnostic testing in occupational asthma. (1999) (13)
Patients' and primary care physicians' beliefs about asthma control and risk. (2009) (13)
Yellow Fever Vaccine I. Development of a Vaccine Seed Free from Contaminating Avian Leukosis Viruses (1968) (13)
The heterogeneity of asthmatic patients--an individualized approach to diagnosis and treatment. (1976) (13)
Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma (2014) (13)
Efficacy and Safety of Budesonide Inhalation Powder (Pulmicort Turbuhaler®) During 52 Weeks of Treatment in Adults and Children with Persistent Asthma (2003) (13)
Multi-center, double-blind, placebo-controlled trial of fluocortin butyl in perennial rhinitis. (1983) (13)
Advances in allergic skin disease: omalizumab is a promising therapy for urticaria and angioedema. (2009) (12)
Provocation studies in the diagnosis of occupational asthma. (2003) (12)
Immediate and delayed type hypersensitivity to malathion. (1992) (12)
Allergy diagnostic testing (2008) (12)
Yellow Fever Vaccine. IV. Reactogenicity and Antibody Response in Volunteers Inoculated With a Vaccine Free From Contaminating Avian Leukosis Viruses (1972) (12)
A comparison of imaging techniques in patients with chronic sinusitis (X-ray, MRI, A-mode ultrasound). (1995) (11)
Establishing practice parameters. (1995) (11)
Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes. (1986) (11)
251 Phase I study of anti-IgE recombinant humanized monoclonal antibody rhuMAB-E25 (E25) in adults with moderate to severe asthma (1996) (11)
Asthma in the Workplace, 3rd ed (Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein DI, editors) (2006) (11)
Clinical Responses and Serum Prostaglandin Levels in Aspirin Idiosyncrasy: Effect of Aspirin and a New Nonsteroidal Anti-Inflammatory Agent (1981) (10)
Adenovirus in the sinuses of an asthmatic patient with apparent selective antibody deficiencies. (1973) (9)
Relationship between serum theophylline levels and pulmonary function before and after inhaled beta-agonist in "stable" asthmatics. (1983) (9)
Defibrination syndrome in a patient with chronic thrombocytopenic purpura. (1969) (9)
Workshop 6: Compliance factors (1986) (9)
Cetirizine, a Novel Antihistamine (1987) (9)
Treatment of the unusually difficult asthmatic patient. (1997) (9)
When allergies and asthma complicate pregnancy. (1998) (9)
Anticholinergic Agents in the Upper and Lower Airways (1999) (9)
Common triggers of asthma. (1991) (9)
Inhalation challenge in asthmatics (1973) (8)
Indications for inhalation challenge (1979) (8)
Stinging insect hypersensitivity: a practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. (1999) (8)
Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture. (2000) (8)
Use of Mannitol Inhalation Challenge in Assessment of Cough (2009) (8)
Atopy reconsidered * (1976) (8)
Acute respiratory emergencies in emergency treatment of the injured athlete. (1989) (8)
4 The effect of food on once daily theo-dur® in asthmatic subjects (1985) (8)
Allergy Diagnostic Testing: An Updated Practice (2008) (8)
Pathophysiology and pharmacotherapy of allergic rhinitis. Foreword. (1999) (8)
Exercise-induced bronchoconstriction update: therapeutic management. (2012) (7)
Asthma and nonsteroidal anti-inflammatory drugs. (1978) (7)
Histopathology and immunofluorescent immunoglobulins in asthmatics with aspirin idiosyncrasy. (1987) (7)
Effect of bronkosol and its components on cardiopulmonary parameters in asthmatic patients. (1977) (7)
Cardio-selective beta-adrenergic therapy in a patient with asthma and hypertrophic obstructive cardiomyopathy. (1981) (6)
Effect of various methods of removing non-specific inhibitors to virus hemagglutination upon serum proteins and immunoglobulins (2005) (6)
ALLERGIC AND NONALLERGIC RHINITIS: UPDATE ON PATHOPHYSIOLOGY AND CLINICAL MANAGEMENT (1995) (6)
Management of asthma with zafirlukast. Clinical experience and tolerability profile. (1996) (6)
Establishing practice parameters: parameters for the diagnosis and treatment of asthma. (1993) (6)
1 A short term comparison of two sustained release (SR) theophylline (T) preparations in asthmatic children (1985) (6)
Chronic Cough: The Allergist’s Perspective (2007) (5)
Tolerance to beta-adrenergics and results of rising dose studies of albuterol, isoproterenol and placebo. (1981) (5)
Management of Asthma with Zafirlukast (2012) (5)
The treatment of the asthmatic mother during pregnancy and lactation. (1983) (5)
Reciprocal relationship between pregnancy and pulmonary disease. State of the art. (1984) (5)
Paranasal sinus anatomy and pathophysiology. (1984) (5)
More on patient compliance. (1989) (5)
205 Evaluation of dermestid sensitivity in museum personnel (1991) (5)
Comments on bronchial inhalation provocative tests (1971) (5)
Controversial and unproven techniques. Position statement from the ACCP section on allergy and clinical immunology. (1984) (5)
Preliminary proposal for practice parameters. (1995) (4)
Antileukotriene agents. (1997) (4)
Scuba diving in individuals with asthma. (1996) (4)
Yellow fever vaccine. II. Antigenicity and neurovirulence of a vaccine seed free from avian leukosis virus. (1969) (4)
Preface: Intranasal anticholinergic treatment of nasal disorders (1992) (4)
More implications of reactivity characteristics to methacholine and histamine in asthmatic patients. (1979) (4)
Bronchial inhalation challenge procedures with allergens and other bronchoconstrictor substances. (1996) (4)
Adverse reactions associated with parenteral beta agonists: serum potassium changes. (1987) (4)
Use of provocation techniques for the evaluation of drug efficacy. (1979) (4)
Alternative treatments in the patient with intractable asthma (1997) (4)
408 Prevalence of dust mites in the homes of asthmatics in several U.S. Geographical regions (1988) (4)
Pulmonary infiltration with eosinophila. Recurrence in an asthmatic patient treated with beclomethasone dipropionate. (1977) (4)
Leukotriene Activity Modulation in Asthma (1997) (3)
Safety and Tolerability of a Budesonide/Formoterol (BUD/FM) Pressurized Metered-Dose Inhaler (pMDI) in Black Adolescents and Adults With Moderate to Severe Persistent Asthma (2010) (3)
Asthma and Exercise (2002) (3)
Morrow-Brown needles revisited. (1993) (3)
Blockage of a "nonspecific" provocational challenge as a model for predicting clinical efficacy. (1990) (3)
Use of antileukotriene agents in asthma management (2000) (3)
Chronic cough. (1997) (2)
These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. (1996) (2)
Ocular, nasal and oral cromolyn sodium in the management of non-asthmatic allergic problems. (1989) (2)
Efficacy of anti-LT agents in the treatment of chronic asthma (1999) (2)
Management of the Pregnant Asthmatic (1994) (2)
Management of chronic idiopathic urticaria. (1989) (2)
Letter: Maximal midexpiratory flow as an index of acute airway changes. (1975) (2)
Labile Blood Eosinophilia in Asthma (2011) (2)
The role of suggestion in asthma. (1988) (2)
1015 Evaluation of efficacy and duration of action of levocabastine (LEVO) nasal spray under nasal challenge conditions (1996) (2)
Isoproterenol, Asthma, and the Heart (1975) (2)
Overview of comorbid associations of allergic rhinitis : New insights into allergic rhinitis: Quality of life, associated airway diseases, and antihistamine potency (1997) (2)
Alpha-adrenergic antagonists in asthmatic patients: a note of caution. (1979) (2)
Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol. (1990) (2)
Multi-Test versus Morrow Brown needle. (1990) (2)
Fatal consequence of allergic rhinitis. (2010) (2)
Implications of practice parameters (guidelines). (1995) (2)
Outpatient treatment of asthma. (1989) (2)
Asthma and bronchitis. (1976) (1)
1005 Evaluation of safety and efficacy of dexacort™ turbinaire® (DEX) nasal spray in patients with perennial allergic rhinitis (1996) (1)
Bronchial hyperreactivity to distilled water and saline. (1982) (1)
314 Use of a smell test in the assessment of nasal function (1991) (1)
Relationship between Serum Theophylline Levels and Pulmonary Function Before and After Inhaled Beta-Agonist in “Stable” Asthmatics1–3 (2015) (1)
Optimum Management of Asthma in Pregnancy (1986) (1)
Indications for inhalation challenge. Study Group on Indications, Bronchoprovocation Committee, American Academy of Allergy. (1979) (1)
694 Relationship between asthma and scuba diving mortality (1991) (1)
Ultraslow Release Theophylline in the Pediatric Patient (1988) (1)
Oral steroid therapy for asthma and contact dermatitis. (1992) (1)
Bronchial exercise and oral challenge procedures. (1981) (1)
HIGH-DOSE INHALED STEROIDS (1996) (1)
Yellow Fever Virus (1929) (1)
Management of Asthma with Zafirlukast Experience and Tolerability Profile (1996) (1)
Leukotrienes and the mechanism by which the LTRAs block their asthma-related effects. (2000) (1)
Asthma and chronic obstructive lung disease: a pharmacologic approach. (1991) (1)
Sinusitis: Pathophysiology, Diagnosis, and Management (1987) (1)
449 Evaluation of the safety and efficacy of long term use of multiple doses of azelastine (AZ) in asthmatics (1988) (1)
Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler vs Budesonide Dry Powder Inhaler on Pulmonary Function in Black Adolescents and Adults With Moderate to Severe Persistent Asthma (2010) (1)
Advances in the treatment of bronchial asthma. (1985) (0)
Anticholinergic Therapy for Allergic and Nonallergic Rhinitis and the Common Cold, Aspen, Colorado, August 1994 (1995) (0)
Antileukotriene Agents in the Management of Asthma (2007) (0)
Algorithm and annotations of sinusitis practice parameters (0)
University of Southern Denmark Efficacy and safety of omalizumab in patients with chronic idiopathic / spontaneous urticaria who remain symptomatic on H 1 antihistamines a randomized , placebo-controlled study (2010) (0)
Awareness of Asthma Control and Asthma Risks: Results of the GAP II Survey of Patients and Primary Care Physicians (2009) (0)
Antileukotrienes--1997 and beyond. (1997) (0)
346 Comparison of the duration of action of terbutaline (T) tablets and albuterol repetabs (AR) (1988) (0)
EDITORIAL Sinusitis and Asthma (1990) (0)
School Performance and Theophylline (1987) (0)
246 Comparison of Rast, Fast and Fast-Plus with skin tests (1988) (0)
Combination Therapy for HIV Disease (2005) (0)
Theophylline dose-dumping. (1986) (0)
Relationship Between Body Mass Index (BMI) and Baseline Characteristics in Non-Black and Black Populations With Moderate to Severe Persistent Asthma (2011) (0)
Clinical response and serum prostaglandin levels in aspirin idiosyncrasy. Effect of aspirin and a new nonsteroidal anti-inflammatory agent. (1981) (0)
Letter: Isoproterenol, asthma, and the heart. (1975) (0)
Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. (2000) (0)
Food allergy , dermatologic diseases , and anaphylaxis Practice parameter Stinging insect hypersensitivity : A Practice Parameter Update (2004) (0)
PATHOGENESIS AND TREATMENT OF UPPER RESPIRATORY INFECTIONS (1999) (0)
withvariable hypogammaglobulinemia in a patient Alpha 1-antitrypsin deficiency and common (2006) (0)
Yellow Fever Vaccine. II. Antigenicity and Neurovirulence of a Vaccine Seed Free from Avian Leukosis Virus (1969) (0)
Update on asthma therapy. (1988) (0)
Yellow Fever Virus. II. Factors Affecting the Plaque Neutralization Test (1969) (0)
Examine your Morrow Brown needles. (1991) (0)
345 Albuterol aerosol vs dry powder(ventolin rotacaps®) for treatment of asthma in children (1988) (0)
ONSET OF ACTION OF MOMETASONE FUROATE DPI MEASURED BY OSCILLOMETRY AND SPIROMETRY (2008) (0)
with Beclomethasone Diproponate (2017) (0)
A 26-week, Open-label Extension Study Evaluating The Long-term Safety And Tolerability Of Ciclesonide Hydrofluoroalkane Nasal Aerosol In Patients With Perennial Allergic Rhinitis (2012) (0)
628 Bronchodilator activity of terfenadine (T), single and steady-state B.I.D. dosing in allergic asthmatics (1991) (0)
In the UnitedStates,wesupportthe approachrecommended by the US Rhinitis Practice Parameters, which recommends NAH as first-line therapy. 2 It is our unanimous clinical experience that these medications are useful as a primary therapy. (2016) (0)
School Performance and Theophylline (1987) (0)
Response to Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) by Patient’s Sex in Non-Black and Black Populations With Asthma (2011) (0)
General discussion: What is sinusitis? (1992) (0)
Using antileukotrienes in asthma therapy. (1999) (0)
Clinical and bacteriologic efficacy of telithromycin in patients with acute bacterial sinusitis: A pooled analysis (2005) (0)
Use of Wheeze Monitor Device in the Ambulatory Setting (2015) (0)
Clinical Responses and Serum Prostaglandin (2015) (0)
Topical nebulized montelukast for nasal polyps (2003) (0)
Aerosol and air filter therapy. (1981) (0)
Sensitivity And Specificity Of Inhaled Mannitol And Methacholine For Clinical Diagnosis Of Asthma (2008) (0)
Onset and Duration of Action of Mometasone Inhalation Powder Measured by Impulse Oscillometry (IOS) (2012) (0)
Cough vs Wheezing During Methacholine Challeng (2011) (0)
The Journal of Pulmonary Technique Oximetry BrOnchiectasis tracheOstOmy VentilatiOn acute cOugh (0)
Regarding the article by Zimmerman, et al. (1989) (0)
Physiologic changes that occur in response to allergen induced challenge. (1985) (0)
Mannitol Inhalational Challenge (2012) (0)
Practice parameter Atopic dermatitis : A practice parameter update 2012 (2013) (0)
School performance and theophylline. (1987) (0)
A dose-response study of the bronchodiktor action of azetastine in asthma (1986) (0)
Using antileukotrienes in asthma therapy. (1999) (0)

This paper list is powered by the following services:

Sheldon Laurence Spector's Academic­Influence.com Rankings

Sheldon Laurence Spector's Degrees

Why Is Sheldon Laurence Spector Influential?

Sheldon Laurence Spector's Published Works

Published Works

Sheldon Laurence Spector's AcademicInfluence.com Rankings